EVALUATION OF DRUG INTERACTION POTENTIAL OF THE HCV PROTEASE INHIBITOR BMS-650032 AT 200MG TWICE DAILY (BID) IN METABOLIC COCKTAIL AND P-GLYCOPROTEIN (P-GP) PROBE STUDIES IN HEALTHY VOLUNTEERS
HEPATOLOGY(2011)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined